Hence, metastatic melanoma cells (IGR37 and WM266.4) treated with BACE2 inhibitor showed reduction in migration capacity, which was rescued by the administration of rPMEL amyloid fibrils (Fig. S5A–D). The gene discussed is BACE2; the disease is melanoma.